Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 2/20 | 0.64 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMYD3 | Q9H7B4 | 3/20 | 0.39 |
| ▸ | CCR1 | P32246 | 1/20 | 0.38 |
| ▸ | STING1 | Q86WV6 | 5/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.35 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2054138 | 1.00 | HCRTR1 (0.64) | HCRTR1HCRTR2RAB9ASMYD3CCR1 | |
| SCHEMBL2014186 | 0.84 | HCRTR1 (0.60) | HCRTR1HCRTR2RAB9ACCR1ITGB1 | |
| SCHEMBL2013656 | 0.84 | HCRTR1 (0.66) | HCRTR1HCRTR2SMYD3CCR1STING1 | |
| SCHEMBL2011420 | 0.81 | HCRTR1 (0.65) | HCRTR1HCRTR2SMYD3STING1 | |
| SCHEMBL2051392 | 0.81 | HCRTR1 (0.66) | HCRTR1HCRTR2SMYD3KMT2A | |
| SCHEMBL2013146 | 0.81 | HCRTR1 (0.66) | HCRTR1HCRTR2SMYD3KMT2A | |
| SCHEMBL2012845 | 0.81 | HCRTR1 (0.64) | HCRTR1HCRTR2SMYD3STING1L3MBTL1 | |
| SCHEMBL2053609 | 0.81 | HCRTR1 (0.64) | HCRTR1HCRTR2SMYD3STING1L3MBTL1 | |
| SCHEMBL2013557 | 0.81 | HCRTR1 (0.64) | HCRTR1HCRTR2SMYD3STING1L3MBTL1 | |
| SCHEMBL2013624 | 0.81 | HCRTR1 (0.60) | HCRTR1HCRTR2SMYD3STING1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011073316-A1 | 4-ARYL-BUTANE-1,3-DIAMIDES | NOVARTIS AG (CH) | 2011-06-23 | — | — | WO | claimed |
| WO-2011073316-A1 | 4-ARYL-BUTANE-1,3-DIAMIDES | NOVARTIS AG (CH) | 2011-06-23 | — | — | WO | disclosed |